Cytotoxic Activity of +/+, mi/mi, and tg/tg CMCs to YAC-1 Cells
E/T Ratio . | Specific51Cr Release (%)* . | |||
---|---|---|---|---|
+/+ CMCs . | mi/mi CMCs . | tg/tg CMCs . | +/+ Spleen Cells . | |
50 | <0.1 | <0.1 | <0.1 | 50.8 ± 2.4 |
100 | 13.9 ± 0.1† | <0.1 | 12.0 ± 0.6† | 57.3 ± 3.8 |
250 | 21.1 ± 2.8† | <0.1 | 19.0 ± 1.9† | NE |
E/T Ratio . | Specific51Cr Release (%)* . | |||
---|---|---|---|---|
+/+ CMCs . | mi/mi CMCs . | tg/tg CMCs . | +/+ Spleen Cells . | |
50 | <0.1 | <0.1 | <0.1 | 50.8 ± 2.4 |
100 | 13.9 ± 0.1† | <0.1 | 12.0 ± 0.6† | 57.3 ± 3.8 |
250 | 21.1 ± 2.8† | <0.1 | 19.0 ± 1.9† | NE |